Please use this identifier to cite or link to this item: http://docs.prosentient.com.au/prosentientjspui/handle/1/13523
Title: Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Authors: Reck M
Robinson AG
Hui R
Cs?szi T
Gottfried M
Peled N
Tafreshi A
Cuffe S
O'Brien M
Rao S
Hotta K
Vandormael K
Riccio A
Yang J
Pietanza MC
Brahmer JR.
Issue Date: 2019
Citation: J Clin Oncol. 2019 Mar 1;37(7):537-546. doi: 10.1200/JCO.18.00149. Epub 2019 Jan 8.
metadata.dc.identifier.journaltitle: J Clin Oncol
URI: 
metadata.dc.identifier.doi: 10.1200/JCO.18.00149
Appears in Collections:ISLHD research

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.